11 March 2026 - AcuraStem, a biotechnology company developing disease-modifying therapies for amyotrophic lateral sclerosis (ALS), announced on Tuesday that it has received a two-year research grant from non-profit organisation Target ALS to advance ...
10 March 2026 - Immuno-oncology company Agenus Inc (Nasdaq:AGEN) said on Tuesday that it has triggered the first USD20m contingent payment under its strategic collaboration with Zydus Lifesciences Ltd.The payment was activated through contracted work...
10 March 2026 - Medical technology company HeartBeam Inc (NASDAQ:BEAT) on Tuesday announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the development and validation of next-generation AI-ECG ...